Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Transgenic pig livers expressing complement regulating proteins: The Nextran collaboration between DNXX and Baxter received FDA clearance to begin a Phase I tri

The transgenic livers will be used as an ex vivo temporary organ

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE